Obstet Gynecol Sci.  2021 May;64(3):309-316. 10.5468/ogs.20349.

Uterine artery Doppler indices: pulsatility index and resistance index as predictive tools for the incidence of heavy menstrual bleeding related to copper intrauterine contraceptive device

Affiliations
  • 1Department of Obstetrics and Gynecology, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Abstract


Objectives
To assess the predictive value of the initial uterine artery Doppler indices, the pulsatility index (PI), and resistance index (RI) in the prediction of heavy menstrual bleeding before and after copper intrauterine contraceptive device (IUCD) insertion.
Methods
The current prospective clinical study included 100 women who intended to use a copper IUCD (Cu T-380A) and met the inclusion criteria. Uterine artery Doppler PI and RI indices were calculated before IUCD insertion and at three and six months after insertion. Based on the presence or absence of menorrhagia, all women were classified into two groups: non-bleeding (n=52) and extreme menstrual bleeding (n=48). Receiver operating curve analysis was used to determine the predictive value of uterine artery PI and RI in patients with menorrhagia relevant to IUCD.
Results
The PI and RI indices displayed a highly significant difference between the IUCD groups at three and six months after insertion (P<0.001). Uterine artery PI ≤2.02 (sensitivity of 95.8%, specificity of 100%, and area below the curve [AUC] of 0.97 at P-value<0.001) and RI ≤0.83 (sensitivity of 93.8%, specificity of 100%, and AUC of 0.949 at P-value<0.001) were correlated with significant menstrual bleeding following insertion of IUCD.
Conclusion
The presented results confirmed our assumption that the initial studies of uterine artery Doppler can predict heavy-menstrual bleeding associated with IUCD and therefore, should be conducted in women pursuing reversible longacting contraception.

Keyword

Copper intrauterine contraceptive device; Transvaginal Doppler ultrasound; Pulsatility index and resistance index

Figure

  • Fig. 1 Receiver operating characteristic curve of pulsatility index (A) and resistance index (B) before intrauterine contraceptive device (IUCD) insertion as a predictor for IUCD-related heavy menstrual bleeding. AUC, area below the curve.

  • Fig. 2 Doppler indices of uterine artery (resistance index [RI] and pulsatility index [PI]) and endometrial thickness in the bleeding group before the insertion.

  • Fig. 3 Doppler indices of uterine artery (resistance index [RI] and pulsatility index [PI]) and endometrial thickness of a patient in the bleeding group, three months after insertion.

  • Fig. 4 Doppler indices of uterine artery (resistance index [RI] and pulsatility index [PI]) and endometrial thickness in non-bleeding group, three months after insertion.


Reference

References

1. Thiery M. Intrauterine contraception: from silver ring to intrauterine contraceptive implant. Eur J Obstet Gynecol Reprod Biol. 2000; 90:145–52.
Article
2. Lin X, Wei M, Li TC, Huang Q, Huang D, Zhou F, et al. A comparison of intrauterine balloon, intrauterine contraceptive device and hyaluronic acid gel in the prevention of adhesion reformation following hysteroscopic surgery for Asherman syndrome: a cohort study. Eur J Obstet Gynecol Reprod Biol. 2013; 170:512–6.
Article
3. Stoddard A, McNicholas C, Peipert JF. Efficacy and safety of long-acting reversible contraception. Drugs. 2011; 71:969–80.
Article
4. Fadiloglu S, Dilbaz B, Fadiloglu E, Dilbaz S. Relationship between copper IUD complications and ultrasonographic findings. Arch Gynecol Obstet. 2018; 297:989–96.
Article
5. Mutlu I, Demir A, Mutlu MF. Can uterine artery Doppler parameters predict copper intrauterine device-induced side effects? Eur J Contracept Reprod Health Care. 2013; 19:51–6.
Article
6. Rezk M, Elkelani O, Gaber W, Shawky M. Pre-insertion uterine artery Doppler indices may predict intrauterine contraceptive device-related heavy menstrual bleeding. Middle East Fertil Soc J. 2018; 23:496–500.
Article
7. Mohamed RS, Abdel Hakim SF. Uterine artery doppler as predictor of side effects in copper intrauterine device users. Al-Azhar Assiut Med J. 2015; 13:63–71.
8. Larsson B. Reply to Drs. Salgo and Oster. Am J Obstet Gynecol. 1977; 128:921–2.
Article
9. Gbarbea E. Contraception: past, present, and future [dissertation]. [Boston]: Boston University School of Medicine;2015. 1–58.
10. Bioscientifica. Contraception: past, present, and future [Internet]. Bristol (UK): Bioscientifica;c2018. [cited 2018 May 10]. Available from: https://www.endocrine-abstracts.org/ea/0056/ea0056pl1.htm.
11. Adeyemi-Fowode O, Bercaw-Pratt J. Intrauterine devices: effective contraception with noncontraceptive benefits for adolescents. J Pediatr Adolesc Gynecol. 2019; 32:S2–6.
Article
12. Bousfield GR, May JV, Davis JS, Dias JA, Kumar TR. In vivo and in vitro impact of carbohydrate variation on human follicle-stimulating hormone function. Front Endocrinol (Lausanne). 2018; 9:216.
Article
13. Fouda UM, Yossef D, Gaafar HM. Uterine artery blood flow in patients with copper intrauterine device-induced abnormal uterine bleeding. Middle East Fertil Soc J. 2010; 15:168–73.
Article
14. Mansour GM, Hussein SH, Mohammed HF, El Mekkawy SF, Akl SA, Abd El Dayem AA. Can we predict menorrhagia with intrauterine contraceptive device (IUCD) insertion? Open J Obstet Gynecol. 2017; 7:753–66.
Article
15. Järvelä I, Tekay A, Jouppila P. The effects of a copper-intrauterine device on the uterine artery blood flow in regularly menstruating women. Hum Reprod. 1998; 13:1841–5.
16. El-Mazny A, Abou-Salem N, Elshenoufy H. Three-dimensional power Doppler study of endometrial and subendometrial microvascularization in women with intrauterine device-induced menorrhagia. Fertil Steril. 2013; 99:1912–57.
Article
17. Jiménez MF, Arbo E, Vetori D, de Freitas FM, Cunha-Filho JSL. The effect of the levonorgestrel-releasing intrauterine system and the copper intrauterine device on subendometrial microvascularization and uterine artery blood flow. Fertil Steril. 2008; 90:1574–8.
Article
Full Text Links
  • OGS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr